ScholarLens Back to search
2016•Journal of clinical lipidologyOpen access

Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses

Julian C. van Capelleveen, John J.P. Kastelein, Aeilko Having Zwinderman, Sander J. H. van Deventer, Heidi L. Collins, Steven J. Adelman, Patrick Round, J. Ford, Daniel James Rader, G. Kees Hovingh

Open full text 38 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 38 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: ABCA1, Cholesterylester transfer protein, High-density lipoprotein, Internal medicine, Endocrinology, Cholesterol, Lipoprotein, Reverse cholesterol transport

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses — Research Paper | ScholarLens